Frontlight ResearchEarly access
Trial site
Suwon
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria4 trials
- Coronary artery disease2 trials
- Lupus (SLE)2 trials
- Stroke2 trials
- Chronic myeloid leukaemia1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Gastric and oesophageal cancer1 trial
- Lung cancer1 trial
- Macular degeneration1 trial
- Myeloproliferative neoplasms1 trial
- Prostate cancer1 trial
- Sjögren's disease1 trial
- Phase
- Phase 311 trials
- Status
- Completed6 trials
- Recruiting6 trials
- Active, not recruiting4 trials
- Lead sponsor
- Novartis Pharmaceuticals16 trials
Running trials
Recruiting
Recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic myeloid leukaemia1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Lupus (SLE)1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Prostate cancer1 recruiting
- Sjögren's disease1 recruiting
Closed trials
Completed
Completed
Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Completed
Completed
Regulatory Post-Marketing Surveillance Study for Brolucizumab
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026